temozolomide has been researched along with mart-1 antigen in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dirilenoglu, F; Mocan, G; Yukselen, OO | 1 |
1 other study(ies) available for temozolomide and mart-1 antigen
| Article | Year |
|---|---|
Spindle cell melanoma coexisting with chronic lymphocytic leukemia/small lymphocytic lymphoma: a rare collision tumor in multiple sites.
Topics: Aged, 80 and over; Antigens, CD20; Antineoplastic Agents, Alkylating; Biopsy; CD5 Antigens; Fatal Outcome; Genes, bcl-2; gp100 Melanoma Antigen; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Male; MART-1 Antigen; Melanoma; Melanoma-Specific Antigens; Neoplasms, Multiple Primary; S100 Proteins; Sentinel Lymph Node Biopsy; Skin Neoplasms; Temozolomide | 2020 |